Abiopharma

🔍 Ye Gang (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Sold 6,014 shares of Class A ordinary shares at $112.48 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 292,778.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 786 shares of Class A ordinary shares at $113.32 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 291,992.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 6,607 shares of Class A ordinary shares at $114.63 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 285,385.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 5,493 shares of Class A ordinary shares at $115.17 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 279,892.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 900 shares of Class A ordinary shares at $116.42 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 278,992.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 200 shares of Class A ordinary shares at $117.63 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 278,792.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 3,616 shares of Class A ordinary shares at $111.72 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 275,176.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 5,012 shares of Class A ordinary shares at $112.99 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 270,164.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 8,032 shares of Class A ordinary shares at $113.7 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 262,132.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 3,340 shares of Class A ordinary shares at $114.46 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 258,792.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-08-31 | Code: H | shares_owned_after: 20,976,405.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on September 4, 2025.
• F2: Represents the weighted average price of shares sold at prices that ranged from $111.97 to $112.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $113.00 to $113.82.
• F4: Represents the weighted average price of shares sold at prices that ranged from $114.06 to $114.96.
• F5: Represents the weighted average price of shares sold at prices that ranged from $114.97 to $115.92.
• F6: Represents the weighted average price of shares sold at prices that ranged from $115.99 to $116.96.
• F7: Represents the weighted average price of shares sold at prices that ranged from $117.49 to $117.77.
• F8: Represents the weighted average price of shares sold at prices that ranged from $111.30 to $112.28.
• F9: Represents the weighted average price of shares sold at prices that ranged from $112.34 to $113.295.
• F10: Represents the weighted average price of shares sold at prices that ranged from $113.30 to $114.29.
• F11: Represents the weighted average price of shares sold at prices that ranged from $114.30 to $114.73.